
TY  - JOUR
TI  - ADF Abstracts 2014
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 23
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.12314
DO  - doi:10.1111/exd.12314
SP  - e1
EP  - e60
PY  - 2014
ER  - 

TY  - JOUR
TI  - Posters on Display
JO  - Pediatric Diabetes
JA  - Pediatr Diabetes
VL  - 18
IS  - S25
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12588
DO  - doi:10.1111/pedi.12588
SP  - 138
EP  - 177
PY  - 2017
ER  - 

TY  - JOUR
TI  - ASBMR 23nd annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 16
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr200116s1s1
DO  - doi:10.1002/jbmr200116s1s1
SP  - S1
EP  - S390
PY  - 2001
ER  - 

TY  - JOUR
TI  - Posters
JO  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
JA  - JDDG: Journal der Deutschen Dermatologischen Gesellschaft
VL  - 12
IS  - s2
SN  - 1610-0379
UR  - https://doi.org/10.1111/j.1610-0387.2014.12387
DO  - doi:10.1111/j.1610-0387.2014.12387
SP  - 14
EP  - 51
PY  - 2014
ER  - 

TY  - JOUR
TI  - Posters
JO  - Bipolar Disorders
JA  - Bipolar Disord
VL  - 20
IS  - S1
SN  - 1398-5647
UR  - https://doi.org/10.1111/bdi.12619
DO  - doi:10.1111/bdi.12619
SP  - 63
EP  - 141
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts of papers presented at the Second Meeting of the European Haematology Association, Paris, France, 29 May-1 June 1996
JO  - British Journal of Haematology
VL  - 93
IS  - S2
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.1996.tb08988.x
DO  - doi:10.1111/j.1365-2141.1996.tb08988.x
SP  - 1
EP  - 372
PY  - 1996
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_1.x
DO  - doi:10.1111/j.1538-7836.2009.03473_1.x
SP  - 1
EP  - 316
PY  - 2009
ER  - 

TY  - JOUR
TI  - 139th Annual Meeting American Neurological Association
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 76
IS  - S18
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.24247
DO  - doi:10.1002/ana.24247
SP  - S1
EP  - S151
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.0300b.x
DO  - doi:10.1111/j.1538-7836.2005.0300b.x
SP  - OR001
EP  - OR396
PY  - 2005
ER  - 

C7  - pp. 417-576
TI  - Glossary and Index
SN  - 9781119975892
UR  - https://doi.org/10.1002/9781119977452.index
DO  - doi:10.1002/9781119977452.index
SP  - 417-576
PY  - 2005
ER  - 

TY  - JOUR
TI  - 2009 Meeting of the Peripheral Nerve Society July 4—8, 2009 Würzburg, Germany
JO  - Journal of the Peripheral Nervous System
VL  - 14
IS  - s2
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1529-8027.2009.00212.x
DO  - doi:10.1111/j.1529-8027.2009.00212.x
SP  - 1
EP  - 163
PY  - 2009
ER  - 

TY  - JOUR
TI  - Free Communications Sessions 33–46 Friday, August 30, 2013
JO  - International Dental Journal
JA  - Int Dent J
VL  - 63
IS  - s1
SN  - 9781119975892
UR  - https://doi.org/10.1111/idj.12051
DO  - doi:10.1111/idj.12051
SP  - 198
EP  - 296
PY  - 2013
ER  - 

TY  - JOUR
TI  - ARA Oral Abstracts
JO  - Internal Medicine Journal
JA  - Intern Med J
VL  - 48
IS  - S4
SN  - 9781119975892
UR  - https://doi.org/10.1111/imj.13772
DO  - doi:10.1111/imj.13772
SP  - 5
EP  - 46
PY  - 2018
ER  - 

TY  - JOUR
TI  - TRANSPLANT 2001: The Joint American Transplant Meeting
JO  - American Journal of Transplantation
VL  - 1
IS  - S1
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1600-6143.2001.tb00014.x
DO  - doi:10.1111/j.1600-6143.2001.tb00014.x
SP  - 47
EP  - 476
PY  - 2001
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 ORAL ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1600-6143.2006.01446.x
DO  - doi:10.1111/j.1600-6143.2006.01446.x
SP  - 65
EP  - 472
PY  - 2006
ER  - 

TY  - JOUR
TI  - American Association of Anatomists. Eighty-second annual session; Boston University School Of Medicine, Harvard Medical School, University of Massachusetts School of Medicine, Tufts University School Of Medicine, April 1, 2, 3, 4, 1969. Officers, abstracts, demonstrations
JO  - The Anatomical Record
JA  - Anat. Rec.
VL  - 163
IS  - 2
SN  - 9781119975892
UR  - https://doi.org/10.1002/ar.1091630203
DO  - doi:10.1002/ar.1091630203
SP  - 139
EP  - 347
PY  - 1969
ER  - 

TY  - JOUR
AU  - Patriarca, Francesca
AU  - Petrucci, Maria T.
AU  - Bringhen, Sara.
AU  - Baldini, Luca
AU  - Caravita, Tommaso
AU  - Corradini, Paolo
AU  - Corso, Alessandro
AU  - Di Raimondo, Francesco
AU  - Falcone, Antonietta
AU  - Ferrara, Felicetto
AU  - Morabito, Fortunato
AU  - Musto, Pellegrino
AU  - Offidani, Massimo
AU  - Petrini, Mario
AU  - Rizzi, Rita
AU  - Semenzato, Gianpietro
AU  - Tosi, Patrizia
AU  - Vacca, Angelo
AU  - Cavo, Michele
AU  - Boccadoro, Mario
AU  - Palumbo, Antonio
TI  - Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
JO  - European Journal of Haematology
VL  - 82
IS  - 2
SN  - 9781119975892
UR  - https://doi.org/10.1111/j.1600-0609.2008.01179.x
DO  - doi:10.1111/j.1600-0609.2008.01179.x
SP  - 93
EP  - 105
KW  - myeloma
KW  - clinical practice guidelines
KW  - chemotherapy
KW  - transplantation
PY  - 2009
AB  - Abstract Purpose and basic procedure of the study:? The availability of new targeted therapies has revolutionised the treatment of multiple myeloma (MM), for both the newly diagnosed and the relapsed and refractory settings. A panel of Italian experts provided guidelines for optimal clinical practice in the treatment of MM. Main findings and conclusions:? The panel recommended that treatment should only be initiated in symptomatic patients. Autologous stem cell transplantation (ASCT) with melphalan is the treatment of choice in patients younger than 65?yr, and induction therapy including new drugs seems the most suitable preparatory regimen before ASCT. In patients who fail to achieve at least a very good partial response (VGPR) after transplant, a consolidation with a second transplant is of clinical benefit. Also, there is evidence that maintenance with thalidomide after ASCT in young patients failing to reach at least VGPR could prolong survival. In elderly patients, the combination of an alkylating drug with a novel agent should be considered as standard approach. Relapsed MM should be retreated after the reappearance of symptoms and signs of organ and tissue damage. Salvage regimens should include corticosteroids plus bortezomib, thalidomide or lenalidomide.
ER  - 

TY  - JOUR
TI  - 41st Annual Meeting of the Society for Pediatric Dermatology July 9 – 12, 2015 • Boston, Massachusetts Presented Posters (PDFs of the posters can be found at www.pedsderm.net)
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 32
IS  - 5
SN  - 9781119975892
UR  - https://doi.org/10.1111/pde.12702
DO  - doi:10.1111/pde.12702
SP  - 742
EP  - 776
PY  - 2015
ER  - 

TY  - JOUR
TI  - 134th Annual Meeting Poster Session Abstracts Monday, October 12, 2009
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 66
IS  - S1
SN  - 9781119975892
UR  - https://doi.org/10.1002/ana.21857
DO  - doi:10.1002/ana.21857
SP  - S4
EP  - S61
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster session 5: Nonmotor aspects of movement disorders, clinical, Parkinsonism
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 17
IS  - S5
SN  - 9781119975892
UR  - https://doi.org/10.1002/mds.10353
DO  - doi:10.1002/mds.10353
SP  - S218
EP  - S263
PY  - 2002
ER  - 
